Get 20% lifetime commission for referring investors to digrin.com
here.
Greenwich LifeSciences, Inc. ( GLSI) - Key Metrics
GLSI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.27 | -$0.13 | -$0.13 |
| 2026Q1 | $0 | -$0.39 | -$0.32 | -$0.32 |
| 2025Q4 | $0 | -$0.58 | -$0.23 | -$0.23 |
| 2025Q3 | $0 | -$0.30 | -$0.20 | -$0.20 |
| 2025Q2 | $0 | -$0.30 | -$0.17 | -$0.17 |
GLSI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -21.72 |
| 2026Q1 | 0% | -15.40 |
| 2025Q4 | 0% | -9.06 |
| 2025Q3 | 0% | -8.29 |
| 2025Q2 | 0% | -7.56 |
GLSI
Price: $17.29
52 week price:
Earnings Per Share: -1.59 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 30476
Market Capitalization: 246.6 million